Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
about
Effect of gamma-mangostin through the inhibition of 5-hydroxy-tryptamine2A receptors in 5-fluoro-alpha-methyltryptamine-induced head-twitch responses of miceRepeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulationInvolvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to ratsThe pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to ratsBehavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.Animal models of depression: are there any?The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.Neuropharmacology of 5-hydroxytryptamine.Animal models of serotonin behavior.Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.Neurochemical correlates of behaviour--content of tryptophan, 5-hydroxytryptophan, serotonin, 5-hydroxyindoleacetic acid, tyrosine, dopamine and norepinephrine in four brain parts of the pigeon during behavioural depression following an injection of(-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system.Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.Environmental, toxicological and related aspects of tryptophan metabolism with particular reference to the central nervous system.Behavioral effects of serotonin neurotoxins: an overview.A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses.Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.Interactions of hallucinogens at the clinical level.The prevention by inhibitors of brain proptein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of L-tryptophan or 5-methoxy-N,N-dimethyltryptamine.A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.Proceedings: The effect of mescaline on defaecation in seven inbred strains of laboratory mice.Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor.Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT.The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.5HT-2 mediation of acute behavioral effects of hallucinogens in rats.Neurochemical correlates of behavior. Content of tryptophan, 5-hydroxytryptophan, serotonin, 5-hydroxyindoleacetic acid, tyrosine, dopamine and norepinephrine in a nerve ending fraction isolated from three brain areas of the pigeon during the periodEvidence that 5-methoxy-N, N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome.TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats.
P2860
Q24672707-AD5157ED-6CAD-43DE-A84C-B13D10156DDBQ28323603-C27DDB9E-9DC6-4BEE-BA93-75878826D60FQ28339792-D6EB66E4-FE84-45D8-A9D6-608A02AA3B66Q28344876-B5E8DFC3-7946-42CB-8EA6-6016F281B7CCQ30358201-D3F7F271-8FB7-4D6C-B1BB-2D43A87C38D3Q34781182-15E4747F-C90A-4C4A-9C94-3B68685E46B3Q35136039-18A029C1-92FE-4689-A9F8-8ACED1295A18Q35177729-490AE57B-DEF5-465D-A17C-9AE89BD07700Q35275821-01049014-EFC7-4D48-8128-2F81F622B456Q35745285-ED80F59B-5D69-4A1C-AF88-E65A96F4DF28Q36364408-F6C2FA2A-CC4D-4C50-87B0-F31BE30E0250Q38004430-6CDCE2C5-2550-4518-9C74-386ADE84C86DQ39080630-5E7D3170-F53F-4E54-AC71-8F693894B2E2Q39090087-78E54348-627F-40FF-8601-DB7386D57950Q39109775-8C272389-D79E-42F8-BAAE-8B75915ACA17Q39195285-CA1EB67A-3575-49CE-9CBC-406FA3618BE6Q39217196-2FBACE96-FF60-4565-98BD-BCF6D9682976Q39710466-25266273-4518-4519-96AE-91B85F621831Q39776034-30EBC759-B499-4103-8BE3-316895F536DBQ39929263-12D385DD-E2B1-452B-A0D5-98A480CCD9BDQ39932207-8EB2DF67-D217-4579-8A08-953DACAF1713Q40050309-248468D4-3BF6-4AEA-AB2F-09992CB45CA0Q40483217-FD062076-128A-439F-8EB0-12653D9D9206Q40692575-5AA77291-4987-4679-8141-3BFD7F0F5DECQ40747144-788DB7F0-591A-4E02-B3D3-145950755F28Q40802682-98598C8C-1831-493D-AB01-BDE3C8F576A1Q40916433-725F5C37-4F8B-4601-8C9C-C8F91BF357F2Q41740406-E7D8FEDC-1AF7-414F-AD88-42516968901BQ41833385-2AA80667-B3C2-456F-A95C-0C2DE568FE41Q41937269-4B498C61-D1DF-4D4B-A609-6714CEC03B1BQ42150372-C9EFEABC-FA82-4445-9BD7-BB5D4DDA6177Q42518284-5080D5E5-0643-4474-AD84-81C4AAEB3AF1Q42690627-0978DAA1-1E2A-45B6-A60B-8791A632C03DQ43000564-C2C64066-8F69-4B48-A29D-46E331EAA43CQ46108266-B7C3BE53-3B4C-4788-96A2-E91F3DB154B6Q48364809-02FC2A88-6AE0-4A95-8FFE-4579AA2600C4Q48492631-3B5BF3A4-A536-474E-9C12-9F5459939A2DQ48514765-27983B99-D24C-48BA-9D05-25B6DF623F3E
P2860
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh
1971年學術文章
@zh-hant
name
Inhibitory effect of chlorprom ...... a monoamine oxidase inhibitor.
@en
Inhibitory effect of chlorprom ...... a monoamine oxidase inhibitor.
@nl
type
label
Inhibitory effect of chlorprom ...... a monoamine oxidase inhibitor.
@en
Inhibitory effect of chlorprom ...... a monoamine oxidase inhibitor.
@nl
prefLabel
Inhibitory effect of chlorprom ...... a monoamine oxidase inhibitor.
@en
Inhibitory effect of chlorprom ...... a monoamine oxidase inhibitor.
@nl
P2860
P1476
Inhibitory effect of chlorprom ...... a monoamine oxidase inhibitor.
@en
P2093
Grahame-Smith DG
P2860
P304
P356
10.1111/J.1476-5381.1971.TB07222.X
P407
P577
1971-12-01T00:00:00Z